Literature DB >> 16437688

Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats.

Chun-Hui Li1, Dong-Ming Piao, Wen-Xie Xu, Zheng-Ri Yin, Jing-Shun Jin, Zhe-Shi Shen.   

Abstract

AIM: To study the morphological and serum hyaluronic acid (HA), laminin (LN), and type IV collagen changes in hepatic fibrosis of rats induced by dimethylnitrosamine (DMN).
METHODS: The rat model of liver fibrosis was induced by DMN. Serum HA, type IV collagen, and LN were measured by ELISA. The liver/weight index and morphological changes were examined under electron microscope on d 7, 14, 21, and 28 by immunohistochemical alpha smooth muscle actin alpha-SMA staining as well as Sirius-red and HE staining.
RESULTS: The levels of serum HA, type IV collagen and LN significantly increased from d 7 to d 28 (P = 0.043). The liver/weight index increased on d 7 and decreased on d 28. In the model group, the rat liver stained with HE and Sirius-red showed evident hemorrhage and necrosis in the central vein of hepatic 10 lobules on d 7. Thin fibrotic septa were formed joining central areas of the liver on d 14. The number of alpha-SMA positive cells was markedly increased in the model group. Transitional hepatic stellate cells were observed under electron microscope. All rats in the model group showed micronodular fibrosis in the hepatic parenchyma and a network of alpha-SMA positive cells. Typical myofibroblasts were embedded in the core of a fibrous septum. Compared to the control group, the area-density percentage of collagen fibrosis and pathologic grading were significantly different in the model group (P<0.05) on different d (7, 14, and 28). The area-density percentage of collagen fibrosis in hepatic tissue had a positive correlation with the levels of serum HA, LN, and type IV collagen.
CONCLUSION: The morphological and serum HA, type IV collagen, and LN are changed in DMN-induced liver fibrosis in rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437688      PMCID: PMC4727238          DOI: 10.3748/wjg.v11.i48.7620

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

Review 1.  Preventive strategies in chronic liver disease: part II. Cirrhosis.

Authors:  T R Riley; A M Bhatti
Journal:  Am Fam Physician       Date:  2001-11-15       Impact factor: 3.292

Review 2.  [Therapy of complications of hepatic cirrhosis].

Authors:  U Töx; T Goeser
Journal:  Praxis (Bern 1994)       Date:  2005-05-04

3.  Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allylalcohol.

Authors:  S A Jung; Y H Chung; N H Park; S S Lee; J A Kim; S H Yang; I H Song; Y S Lee; D J Suh; I H Moon
Journal:  Scand J Gastroenterol       Date:  2000-09       Impact factor: 2.423

4.  Dimethylnitrosamine-induced hepatic cirrhosis: a new canine model of an ancient human disease.

Authors:  J W Madden; P M Gertman; E E Peacock
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

5.  [Therapeutic effect of "anti-hepatic-fibrosis 268" on hepatic fibrosis in rats].

Authors:  Nian-song Pan; Sheng-tao Li; Yi Wang; Ming-fu Li; Zhen Han
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2004-07

6.  Protein deficiency and muscle damage in carbon tetrachloride induced liver cirrhosis.

Authors:  A López-Lirola; E González-Reimers; R Martín Olivera; F Santolaria-Fernández; L Galindo-Martín; P Abreu-González; T González-Hernández; F Valladares-Parrilla
Journal:  Food Chem Toxicol       Date:  2003-12       Impact factor: 6.023

7.  Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism.

Authors:  A M Jézéquel; R Mancini; M L Rinaldesi; G Ballardini; M Fallani; F Bianchi; F Orlandi
Journal:  J Hepatol       Date:  1989-01       Impact factor: 25.083

8.  A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat.

Authors:  A M Jézéquel; R Mancini; M L Rinaldesi; G Macarri; C Venturini; F Orlandi
Journal:  J Hepatol       Date:  1987-10       Impact factor: 25.083

9.  Expression of alpha-smooth muscle actin in liver diseases.

Authors:  E Yu; G Choe; G Gong; I Lee
Journal:  J Korean Med Sci       Date:  1993-10       Impact factor: 2.153

Review 10.  Molecular regulation of pancreatic stellate cell function.

Authors:  Robert Jaster
Journal:  Mol Cancer       Date:  2004-10-06       Impact factor: 27.401

View more
  8 in total

1.  Decreased hepatic nerve fiber innervation in patients with liver cirrhosis.

Authors:  Soon Woo Nam; Hyun Joo Song; Su Jung Back; Tae Hun Kim; Se Hyun Cho; Joon-Yeol Han; Kwon Yoo; Young Suk Lee; Kyu Won Chung
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

2.  Beet root (Beta vulgaris) protects lipopolysaccharide and alcohol-induced liver damage in rat.

Authors:  Bae-Hwan Kim; Se-Hoon Jung; Suryun Jung
Journal:  Toxicol Res       Date:  2020-04-01

3.  Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.

Authors:  Kazuya Kitamori; Hisao Naito; Hazuki Tamada; Miya Kobayashi; Daisuke Miyazawa; Yuko Yasui; Kunihiro Sonoda; Satoru Tsuchikura; Naomi Yasui; Katsumi Ikeda; Takashi Moriya; Yukio Yamori; Tamie Nakajima
Journal:  Environ Health Prev Med       Date:  2011-08-19       Impact factor: 3.674

4.  Curative propensity of green tea extract towards hepatic fibrosis induced by CCl(4): A histopathological study.

Authors:  A M Safer; M Afzal; A Nomani; O Sosamma; S A Mousa
Journal:  Exp Ther Med       Date:  2012-03-02       Impact factor: 2.447

5.  Green tea extract therapy diminishes hepatic fibrosis mediated by dual exposure to carbon tetrachloride and ethanol: A histopathological study.

Authors:  Abdel-Majeed Safer; Mohamad Afzal; Nomny Hanafy; Shaker Mousa
Journal:  Exp Ther Med       Date:  2014-12-24       Impact factor: 2.447

6.  Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17.

Authors:  Linhua Zheng; Jindong Chu; Yongquan Shi; Xinmin Zhou; Ling Tan; Qiang Li; Lina Cui; Zheyi Han; Ying Han; Daiming Fan
Journal:  Cell Biosci       Date:  2013-12-06       Impact factor: 7.133

7.  Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats.

Authors:  Hazuki Tamada; Hisao Naito; Kazuya Kitamori; Yumi Hayashi; Nozomi Yamagishi; Masashi Kato; Tamie Nakajima
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

8.  Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride.

Authors:  Yanuo Li; Yan Shi; Yan Sun; Luying Liu; Xianyong Bai; Dong Wang; Hongxing Li
Journal:  Mol Med Rep       Date:  2016-11-24       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.